PhRMA chief plays fa­vorites in sin­gling out Mar­tin Shkre­li as a ‘bad ac­tor’; Roche ex­tends an­tibi­otics col­lab­o­ra­tion

→ PhRMA CEO Steve Ubl en­joys hold­ing up Tur­ing’s Mar­tin Shkre­li as an ex­am­ple of the kind of “bad ac­tors” that are giv­ing phar­ma com­pa­nies a bad name. The Boston Busi­ness Jour­nal not­ed that Ubl sin­gled out Shkre­li in a Q&A with re­porters. But what about Marathon CEO and PhRMA board mem­ber Jeff Aronin, who finds him­self at the cen­ter of a tem­pest over the ap­proval of de­flaza­cort?  STAT notes: “Ubl wouldn’t say what kind of com­pa­nies might get the boot from PhRMA once the mem­ber­ship cri­te­ria are re­vised. But he said the re­vi­sion process ‘should take weeks not months.’ He al­so con­firmed that while Marathon is still a PhRMA mem­ber, it’s pos­si­ble that af­ter the re­view it might not be.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER